Birdwatch Note Rating
2023-04-18 15:15:38 UTC - NOT_HELPFUL
Rated by Participant: 43B796B3CC1094D51FF543934BA6ABDA934279C4BFC46A66D4E9FC35C12658FD
Participant Details
Original Note:
A two-shot course of Pfizer Inc.’s vaccine may have just 22.5% efficacy against symptomatic infection with the omicron variant, but can thwart severe disease, according to laboratory experiments in South Africa. https://www.bloomberg.com/news/articles/2021-12-11/pfizer-course-has-23-efficacy-vs-omicron-in-s-african-study
All Note Details